ArticleFrontiers in immunology2026

Rational design and biological validation of EZH2/PD-L1 bifunctional inhibitors for colorectal cancer immunotherapy.

Bingsheng Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.